← Back to Patent Explorer
US4839174A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel transdermal nicotine patch

Assignee: McNeil AB
•
Filing: 1987-10-05
•
Granted: 1989-06-13
•
Expires: 2007-10-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A controlled release transdermal delivery system for nicotine administration. The system comprises an impermeable backing layer, a polyurethane matrix layer containing between about 5 wt % and 50 wt % nicotine, and an adhesive skin-contacting layer. The system is designed to administer nicotine for smoking cessation therapy or other uses over a period of 24 hours or more.

Inventors

  • 👤 Richard W. Baker
  • 👤 Frank Kochinke
  • 👤 Carl Huang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 16:23
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K9/7038; A61K9/7046; A61K9/7069; A61F; A61F5/00; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/465; A61K9/7084

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 57 words
A transdermal nicotine delivery device, comprising a laminate of: (a) a matrix layer comprising between about 5% and 50% nicotine and between about 95% and 50% polyurethane, said matrix layer having a first and second face; (b) an impermeable and opaque backing layer contacting said first face; and (c) an amine-resistant bioadhesive layer contacting said second face.
Claim 2
Dependent Claim 57 words
A transdermal nicotine delivery device, comprising a laminate of: (a) a matrix layer comprising between about 5% and 50% nicotine and between about 95% and 50% polyurethane, said matrix layer having a first and second face; (b) an impermeable and opaque backing layer contacting said first face; and (c) an amine-resistant bioadhesive layer contacting said second face.
Claim 3
Dependent Claim 58 words
A transdermal nicotine delivery device, comprising a laminate of: (a) a matrix layer comprising between about 5% and 50% nicotine and between about 95% and 50% polyester-type polyurethane, said matrix layer having a first and second face; (b) an impermeable and opaque backing layer contacting said first face; and (c) an amine-resistant bioadhesive layer contacting said second face.
Claim 4
Dependent Claim 58 words
A transdermal nicotine delivery device, comprising a laminate of: (a) a matrix layer comprising between about 5% and 50% nicotine and between about 95% and 50% polyester-type polyurethane, said matrix layer having a first and second face; (b) an impermeable and opaque backing layer contacting said first face; and (c) an amine-resistant bioadhesive layer contacting said second face.
Claim 5
Dependent Claim 27 words
The transdermal device of claim 1 or claim 2, wherein said matrix layer comprises between about 5% and 25% nicotine and between about 95% and 75% polyurethane.
Claim 6
Dependent Claim 19 words
The transdermal device of claim 1 or claim 2, wherein said amine-resistant bioadhesive layer comprises double-sided medical adhesive tape.
Claim 7
Dependent Claim 25 words
The transdermal device of claim 1 or claim 2, wherein said amine-resistant bioadhesive layer has a nicotine flux between 25 and 300 μg/cm 2 ·h.
Claim 8
Independent Claim 74 words
A method for prolonged transdermal delivery of nicotine to a patient, comprising applying to said patient a transdermal nicotine delivery device, comprising a laminate of: (a) a matrix layer comprising between about 5% and 50% nicotine and between about 95% and 50% polyether-type polyurethane, said matrix layer having a first and second face; (b) am impermeable and opaque backing layer contacting said first face; and (c) an amine-resistant bioadhesive layer contacting said second face.
Claim 9
Independent Claim 74 words
A method for prolonged transdermal delivery of nicotine to a patient, comprising applying to said patient a transdermal nicotine delivery device, comprising a laminate of: (a) a matrix layer comprising between about 5% and 50% nicotine and between about 95% and 50% polyether-type polyurethane, said matrix layer having a first and second face; (b) am impermeable and opaque backing layer contacting said first face; and (c) an amine-resistant bioadhesive layer contacting said second face.
Claim 10
Independent Claim 88 words
A method for prolonged transdermal delivery of nicotine to a patient, comprising applying to said patient a transdermal nicotine delivery device, comprising a laminate of: (a) a matrix layer comprising between about 5% and 50% nicotine and between about 95% and 50% polyether-type polyurethane, said matrix layer having a first and second face; (b) an impermeable and opaque backing layer contacting said first face, (c) an amine-resistant bioadhesive layer contacting said second face, said transdermal nicotine device remaining active on the skin for a period of one day.
Claim 11
Independent Claim 88 words
A method for prolonged transdermal delivery of nicotine to a patient, comprising applying to said patient a transdermal nicotine delivery device, comprising a laminate of: (a) a matrix layer comprising between about 5% and 50% nicotine and between about 95% and 50% polyether-type polyurethane, said matrix layer having a first and second face; (b) an impermeable and opaque backing layer contacting said first face, (c) an amine-resistant bioadhesive layer contacting said second face, said transdermal nicotine device remaining active on the skin for a period of one day.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-06-12 1992-12-12 1993-06-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-06-12 1996-12-12 1997-06-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-06-12 2000-12-12 2001-06-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag